All Sites Earlier this month, Oxford Performance Materials Inc. (OPM; South Windsor, CT) received 510(k) clearance from FDA for its 3D-printed OsteoFab Patient-Specific Facial Device (OPSFD). It is the first and, thus far, only 3D-printed polymeric implant for facial indications cleared by FDA, says OPM. The announcement follows FDA clearance in February 2013 of OPM’s OsteoFab Patient-Specific Cranial Device. read more
Excerpt from:
How will first FDA-approved 3D-printed facial implant affect industry?
Tags: 3d printing, medical, qd-syringe